Resources by Therapeutic Area
Skaug B and Assassi S Cytokine. 2019 Jan 23. pii: S1043-4666(19)30006-7 DOI: 10.1016/j.cyto.2018.12.018 ABSTRACT
February 21-22, 2019 Bruges, Belgium
A Phase 2 Trial of Lutikizumab, an Anti-Interleukin 1alpha/beta Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis
Fleischmann RM, Bliddal H, Blanco FJ, Schnitzer TJ, Peterfy C, Chen S, Wang L, Feng S, Conaghan PG, Berenbaum F, Pelletier JP, Martel-Pelletier J, Vaeterlein O, Kaeley GS, Liu W, Kosloski MP, Levy G, Zhang L, Medema JK and Levesque MC. Arthritis Rheumatol. 2019 Jan 17.
Quanterix Extends Oncology Footprint with Accelerated Launch of Next Gen SP-X™ Platform and CorPlex™ Validated 10-Plex
Following successful beta program, the Simoa SP-X next generation benchtop and CorPlex are launching ahead of schedule to further revolutionize cancer research, immunotherapy monitoring, and drug development